Literature DB >> 22669080

Effect of long-term cannabis use on axonal fibre connectivity.

Andrew Zalesky1, Nadia Solowij, Murat Yücel, Dan I Lubman, Michael Takagi, Ian H Harding, Valentina Lorenzetti, Ruopeng Wang, Karissa Searle, Christos Pantelis, Marc Seal.   

Abstract

Cannabis use typically begins during adolescence and early adulthood, a period when cannabinoid receptors are still abundant in white matter pathways across the brain. However, few studies to date have explored the impact of regular cannabis use on white matter structure, with no previous studies examining its impact on axonal connectivity. The aim of this study was to examine axonal fibre pathways across the brain for evidence of microstructural alterations associated with long-term cannabis use and to test whether age of regular cannabis use is associated with severity of any microstructural change. To this end, diffusion-weighted magnetic resonance imaging and brain connectivity mapping techniques were performed in 59 cannabis users with longstanding histories of heavy use and 33 matched controls. Axonal connectivity was found to be impaired in the right fimbria of the hippocampus (fornix), splenium of the corpus callosum and commissural fibres. Radial and axial diffusivity in these pathways were associated with the age at which regular cannabis use commenced. Our findings indicate long-term cannabis use is hazardous to the white matter of the developing brain. Delaying the age at which regular use begins may minimize the severity of microstructural impairment.

Mesh:

Year:  2012        PMID: 22669080     DOI: 10.1093/brain/aws136

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  102 in total

1.  White matter integrity differences associated with post-traumatic stress disorder are not normalized by concurrent marijuana use.

Authors:  Chien-Lin Yeh; Nina Levar; Hannah C Broos; Alyson Dechert; Kevin Potter; A Eden Evins; Jodi M Gilman
Journal:  Psychiatry Res Neuroimaging       Date:  2019-11-14       Impact factor: 2.376

Review 2.  WHY NOT POT?: A Review of the Brain-based Risks of Cannabis.

Authors:  Kai MacDonald; Katherine Pappas
Journal:  Innov Clin Neurosci       Date:  2016-04-01

3.  Neuropsychological performance in adolescent marijuana users with co-occurring alcohol use: A three-year longitudinal study.

Authors:  Joanna Jacobus; Lindsay M Squeglia; M Alejandra Infante; Norma Castro; Ty Brumback; Alejandro D Meruelo; Susan F Tapert
Journal:  Neuropsychology       Date:  2015-05-04       Impact factor: 3.295

Review 4.  Risks associated with the non-medicinal use of cannabis.

Authors:  Eva Hoch; Udo Bonnet; Rainer Thomasius; Florian Ganzer; Ursula Havemann-Reinecke; Ulrich W Preuss
Journal:  Dtsch Arztebl Int       Date:  2015-04-17       Impact factor: 5.594

Review 5.  Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.

Authors:  Alison C Burggren; Anaheed Shirazi; Nathaniel Ginder; Edythe D London
Journal:  Am J Drug Alcohol Abuse       Date:  2019-07-31       Impact factor: 3.829

6.  Functional connectivity and cannabis use in high-risk adolescents.

Authors:  Jon M Houck; Angela D Bryan; Sarah W Feldstein Ewing
Journal:  Am J Drug Alcohol Abuse       Date:  2013-11       Impact factor: 3.829

Review 7.  [Cannabis-induced disorders].

Authors:  M Soyka; U Preuss; E Hoch
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

8.  Anatomical distance affects functional connectivity in patients with schizophrenia and their siblings.

Authors:  Shuixia Guo; Lena Palaniyappan; Bo Yang; Zhening Liu; Zhimin Xue; Jianfeng Feng
Journal:  Schizophr Bull       Date:  2013-11-26       Impact factor: 9.306

9.  Recent rapid decrease in adolescents' perception that marijuana is harmful, but no concurrent increase in use.

Authors:  Aaron L Sarvet; Melanie M Wall; Katherine M Keyes; Magdalena Cerdá; John E Schulenberg; Patrick M O'Malley; Lloyd D Johnston; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2018-03-01       Impact factor: 4.492

10.  COMT val158met and 5-HTTLPR genetic polymorphisms moderate executive control in cannabis users.

Authors:  Antonio Verdejo-García; Ana Beatriz Fagundo; Aida Cuenca; Joan Rodriguez; Elisabet Cuyás; Klaus Langohr; Susana de Sola Llopis; Ester Civit; Magí Farré; Jordi Peña-Casanova; Rafael de la Torre
Journal:  Neuropsychopharmacology       Date:  2013-02-28       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.